Production and purification of Plasmodium circumsporozoite protein in Lactococcus lactis
Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › fagfællebedømt
Standard
Production and purification of Plasmodium circumsporozoite protein in Lactococcus lactis. / Naghizadeh, Mohammad; Singh, Susheel K; Plieskatt, Jordan; Ofori, Ebenezer Addo; Theisen, Michael.
Recombinant Glycoproteins: Methods and Protocols. red. / Steven B. Bradfute. Humana Press, 2024. s. 109-121 (Methods in molecular biology (Clifton, N.J.), Bind 27521).Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - CHAP
T1 - Production and purification of Plasmodium circumsporozoite protein in Lactococcus lactis
AU - Naghizadeh, Mohammad
AU - Singh, Susheel K
AU - Plieskatt, Jordan
AU - Ofori, Ebenezer Addo
AU - Theisen, Michael
N1 - © 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2024
Y1 - 2024
N2 - Malaria is a vector-borne disease caused by Plasmodium parasites of which Plasmodium falciparum contributed to an estimated 247 million cases worldwide in 2021 (WHO malaria report 2022). The P. falciparum Circumsporozoite protein (PfCSP) covers the surface of the sporozoite which is critical to cell invasion in the human host. PfCSP is the leading pre-erythrocytic vaccine candidate and forms the basis of the RTS'S (Mosquirix®) malaria vaccine. However, high-yield production of full-length PfCSP with proper folding has been challenging. Here, we describe expression and purification of full-length PfCSP (containing 4 NVDP and 38 NANP repeats) with proper conformation by a simple three-step procedure in the Lactococcus lactis expression system.
AB - Malaria is a vector-borne disease caused by Plasmodium parasites of which Plasmodium falciparum contributed to an estimated 247 million cases worldwide in 2021 (WHO malaria report 2022). The P. falciparum Circumsporozoite protein (PfCSP) covers the surface of the sporozoite which is critical to cell invasion in the human host. PfCSP is the leading pre-erythrocytic vaccine candidate and forms the basis of the RTS'S (Mosquirix®) malaria vaccine. However, high-yield production of full-length PfCSP with proper folding has been challenging. Here, we describe expression and purification of full-length PfCSP (containing 4 NVDP and 38 NANP repeats) with proper conformation by a simple three-step procedure in the Lactococcus lactis expression system.
U2 - 10.1007/978-1-0716-3666-4_7
DO - 10.1007/978-1-0716-3666-4_7
M3 - Book chapter
C2 - 38315362
T3 - Methods in molecular biology (Clifton, N.J.)
SP - 109
EP - 121
BT - Recombinant Glycoproteins
A2 - Bradfute, Steven B.
PB - Humana Press
ER -
ID: 382902656